Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Broncus Holding Corp. ( (HK:2216) ) has shared an update.
Broncus Holding Corporation reported that all resolutions proposed at its 14 May 2026 annual general meeting were duly passed by shareholders via poll voting. Investors approved the 2025 audited financial statements, reappointed Ernst & Young as auditor, renewed authority for the board to set director pay, and granted mandates for share issuance and buybacks within defined limits.
Shareholders also endorsed the re-election of two non-executive directors, though support for Yanhong Kuang was notably lower than for Ao Zhang, highlighting some investor divergence on board composition. A special resolution to amend the company’s articles of association was comfortably approved, giving the board updated constitutional flexibility that could affect future capital management and governance arrangements.
More about Broncus Holding Corp.
Broncus Holding Corporation is a Cayman Islands–incorporated medical company listed in Hong Kong, focusing on healthcare technologies and related services. The group operates through subsidiaries and is overseen by a board comprising executive, non-executive and independent directors, reflecting a typical governance structure for a listed medical holdings firm.
Average Trading Volume: 759,677
Technical Sentiment Signal: Sell
Current Market Cap: HK$549.9M
See more data about 2216 stock on TipRanks’ Stock Analysis page.